Japan Reconsiders Online, Mail-Order Sales Ban Of Risky Drugs
This article was originally published in PharmAsia News
Executive Summary
Japan had planned to ban online sales of nonprescription drugs deemed to have a moderate to high risk of side effects, but now is reconsidering. The Health, Labor and Welfare Ministry had said earlier the ban would include mail-order sales as well, but it still needs to form a committee to consider whether the proposal is appropriate. Internet retailers, the disabled and the general public raised such an outcry the ministry agreed to review its plan to enact the ban June 1. In addition to considering a ban, the panel also is to study other ways to address the problem of unsafe drugs sold from remote sites. The Japan Pharmaceutical Association supports a ban. (Click here for more - a subscription may be required